A new clinical trial model draws on a database of multisite study findings to advance the discovery of new therapies. The approach is beginning to identify new drugs for difficult to treat breast cancers.
A novel drug combined with standard-of-care chemotherapy provides a successful outcome for a clinical trial participant. The drug therapy is being further evaluated in a phase III trial.Continue reading
Genomic analysis of specific sarcomas and trials of novel chemotherapy regimens provide promising new approaches to treating these rare and challenging cancers.Continue reading
As the population ages, the number of individuals affected by MR is rising. Less-invasive approaches hold promise in improving outcomes for older patients and those who cannot undergo open procedures.Continue reading
The new high-intensity form of phototherapy can reach the inflammatory cells that drive many chronic skin conditions without requiring patients to take photosensitizing medications.Continue reading